Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2022 ∙ Bailey, A. J. M. Maganti, H. B. Cheng, W. Shorr, R. Arianne Buchan, C. Allan, D. S.

Humoral and Cellular Response of Transplant Recipients to a Third Dose of mRNA SARS-CoV-2 Vaccine: A Systematic Review and Meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2022 ∙ Yoo, J. J. Yon, D. K. Lee, S. W. Shin, J. I. Kim, B. K.

Humoral Immunogenicity to SARS-CoV-2 Vaccination in Liver Transplant Recipients: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Martins-Branco, D. Nader-Marta, G. Tecic Vuger, A. Debien, V. Ameye, L. Brandão, M. Punie, K. Loizidou, A. Willard-Gallo, K. Spilleboudt, C. Awada, A. Piccart, M. de Azambuja, E.

Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Shoar, S. Prada-Ruiz, A. C. C. Patarroyo-Aponte, G. Chaudhary, A. Sadegh Asadi, M.

Immune Response to SARS-CoV-2 Vaccine among Heart Transplant Recipients: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Xiao, Karren Gillissie, Emily S. Lui, Leanna M. W. Ceban, Felicia Teopiz, Kayla M. Gill, Hartej Cao, Bing Ho, Roger Rosenblat, Joshua D. McIntyre, Roger S.

Immune Response to Vaccination in Adults with Mental Disorders: A Systematic Review

  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Gombolay, G. Y. Dutt, M. Tyor, W.

Immune responses to SARS-CoV-2 vaccination in multiple sclerosis: a systematic review/meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Bidari, A. Asgarian, S. Mohammad, A. P. Naderi, D. Anaraki, S. R. Mesgarha, M. G. Naderkhani, M.

Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ ElSawi, H. A. Elborollosy, A.

Immune-mediated adverse events post-COVID vaccination and types of vaccines: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Roy, A. Verma, N. Singh, S. Pradhan, P. Taneja, S. Singh, M.

Immune-mediated liver injury following COVID-19 vaccination: A systematic review

  • Adults
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Iheanacho, C. O. Eze, U. I. H.

Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...